EPAS1 and neoplasm: Interestingly, gain of function mutations affecting HIF-2α may also interact with hypoxia, as these mutations have been reported in 80% of patients with PGL in the context of cyanotic heart disease (74), in contrast to 5-6% of all PGL tumours.